SKN Solution LLC – Trademark Portfolio

Entity Type: 16

SKN Solution LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include LILIUM and BLOSSOM ESSENTIALS. The owner is based in Austin, TX.

701 Tillery Street, Suite 12

Austin, TX 78702

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SKN Solution LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (4 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SKN Solution LLC have?

SKN Solution LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 2 abandoned.

What trademark classes does SKN Solution LLC file in?

SKN Solution LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are SKN Solution LLC's most well-known trademarks?

SKN Solution LLC's registered trademark portfolio includes well-known marks such as LILIUM and BLOSSOM ESSENTIALS. These are among 2 currently registered trademarks in the portfolio.

What is SKN Solution LLC's trademark registration success rate?

SKN Solution LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.